Anticancer or antiviral composition
OwnerLae-Ok Parkinventor
Life of this patent
Estimating the term…
Abstract
Disclosed is an anticancer or an antiviral composition comprising therapeutically effective amounts of citric acid and/or zinc and L-arginine along with a pharmaceutically acceptable carrier. The anticancer composition of the present invention has a strong anticancer effect while not having harmful side effects. The antiviral composition of the present invention is useful for treatment of diseases caused by viral infections.
Claims11
An anticancer composition comprising therapeutically effective amounts of citric acid, zinc and L-arginine and a pharmaceutically acceptable carrier, wherein the content of the citric acid is between 0.01% and 20% by weight, the content of the zinc is between 0.001% and 5% by weight, and the content of the L-arginine is between 0.01% and 20% by weight, based on the total weight of the composition.
(canceled)
(canceled)
An antiviral composition comprising therapeutically effective amounts of citric acid, zinc and L-arginine and a pharmaceutically acceptable carrier, wherein the content of the citric acid is between 0.001% and 20% by weight, the content of the zinc is between 0.0001% and 5% by weight, and the content of the L-arginine is between 0.001% and 20% by weight, based on the total weight of the composition.
(canceled)
11-20. (canceled)
Dependencies are inferred from the claim text.